Credit: Nupam Mahajan
A new study from Washington University School of Medicine in St. Louis shows how prostate cancer creates its own hormonal fuel supply in response to anti-testosterone therapy. The study further suggests a strategy to block this process and potentially improve therapy options for treatment-resistant prostate cancer. Shown is a thin slice of a human prostate tumor. The dark staining throughout reveals the presence of histone acetylation promoting cholesterol production. Cholesterol is required to make testosterone, which fuels tumor growth.